作者：
Dustin J,Flanagan [1]
;
Nalle,Pentinmikko [2]
;
Kalle,Luopajärvi [3]
;
Nicky J,Willis [2]
;
Kathryn,Gilroy [3]
;
Alexander P,Raven [4]
;
Lynn,Mcgarry [1]
;
Johanna I,Englund [5]
;
Anna T,Webb [1]
;
Sandra,Scharaw [5]
;
Nadia,Nasreddin [1]
;
Michael C,Hodder [2]
;
Rachel A,Ridgway [3]
;
Emma,Minnee [6]
;
Nathalie,Sphyris [6]
;
Ella,Gilchrist [7]
;
Arafath K,Najumudeen [1]
;
Beatrice,Romagnolo [8]
;
Christine,Perret [1]
;
Ann C,Williams [1]
;
Hans,Clevers [9]
;
Pirjo,Nummela [1]
;
Marianne,Lähde [1]
;
Kari,Alitalo [8]
;
Ville,Hietakangas [1]
;
Ann,Hedley [10]
;
William,Clark [10]
;
Colin,Nixon [11]
;
Kristina,Kirschner [5]
;
E Yvonne,Jones [12]
;
Ari,Ristimäki [13]
;
Simon J,Leedham [14]
;
Paul V,Fish [15]
;
Jean-Paul,Vincent [14]
;
Pekka,Katajisto [15]
;
Owen J,Sansom [2]
作者单位：
Cancer Research UK Beatson Institute, Glasgow, UK.
[1]
Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
[2]
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
[3]
Alzheimer's Research UK UCL Drug Discovery Institute, University College London, London, UK.
[4]
SpecifiCancer CRUK Grand Challenge Team (C7932/A29055), Department of Genetics, Harvard Medical School, Boston, MA, USA.
[5]
Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.
[6]
Intestinal Stem Cell Biology Lab, Wellcome Trust Centre Human Genetics, University of Oxford, Oxford, UK.
[7]
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
[8]
Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
[9]
Université de Paris, Institut Cochin, INSERM, CNRS, Paris, France.
[10]
Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, Faculty of Life Sciences, University of Bristol, Bristol, UK.
[11]
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, The Netherlands.
[12]
Department of Pathology, Applied Tumor Genomics, Research Programs Unit and HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
[13]
Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
[14]
Wihuri Research Institute, University of Helsinki, Helsinki, Finland.
[15]
Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
[16]
The Francis Crick Institute, London, UK.
[17]
Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland. pekka.katajisto@helsinki.fi.
[18]
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland. pekka.katajisto@helsinki.fi.
[19]
Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden. pekka.katajisto@helsinki.fi.
[20]
Cancer Research UK Beatson Institute, Glasgow, UK. o.sansom@beatson.gla.ac.uk.
[21]
SpecifiCancer CRUK Grand Challenge Team (C7932/A29055), Department of Genetics, Harvard Medical School, Boston, MA, USA. o.sansom@beatson.gla.ac.uk.
[22]
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. o.sansom@beatson.gla.ac.uk.
[23]
DOI
10.1038/s41586-021-03525-z
PMID
34079124
发布时间
2024-03-10
换一批
换一批
